PharmaTher Holdings Announces FDA Grant of Orphan Drug Designation to KETARX™...

Silo Pharma Announces Expansion of Intellectual Property Portfolio

Ehave Provides Progress Update on its HPPD Study with University of...

Reunion Neuroscience Schedules Fiscal Third Quarter 2023 Conference Call for Tuesday,...

Mindset Pharma Receives Another Allowance from USPTO for Patent Application Expanding...

The Agenda for Economic Analyses of Psychedelic-assisted Therapy

A Perspective on Providers: Scaling PAT in a Time of Therapist...

Making “Access” A Meaningful Part of Every Conversation about Psychedelic Therapy​

Psychedelic Therapies: From Approvals to Access

PharmaTher Holdings Submits FDA Meeting Package to Discuss Phase 3 Program...

Load more